The long-acting drug delivery (LADD) market is reshaping modern healthcare with injectables, implants, and sustained-release systems that improve patient adherence and therapeutic outcomes. To stay ahead in this fast-evolving domain, here are the top BIS Research reports every stakeholder should explore.
1. Global Long-Acting Drug Delivery Technologies and Services Market Report
Gain a complete picture of the LADD ecosystem—from market forecasts to competitive benchmarking.
- Market size, CAGR, and segmentation across therapy areas
- Insights on injectables, implants, and depot systems
- Key opportunities in oncology, diabetes, infectious diseases, and mental health
2. Global Injectable Drug Delivery Market Report
Deep-dive into long-acting injectables (LAIs) and the future of self-administration devices.
- Prefilled syringes, autoinjectors, and depot systems
- Regional adoption trends and growth hotspots
- Profiles of leading device and pharma players
3. Cell & Gene Therapy Drug Delivery Devices Market Report
Explore how long-acting release systems enable precision in advanced therapeutics.
- Controlled-release technologies for oncology and rare diseases
- Partnerships between biotech firms and device manufacturers
- Innovation trends in delivery solutions
4. Global Biologics Market Report
Understand the link between biologics growth and the demand for specialized long-acting delivery.
- Biosimilars and biologics requiring depot/implant systems
- Regional regulatory insights
- Competitive dynamics among major players
5. Global Transdermal Patches Market Report
Get insights into non-invasive long-acting alternatives to injections.
- Growth in hormone therapy, pain management, neurology
- Advances in adhesion and controlled dosing
- Regional adoption and innovation pipeline
Final Takeaway
These BIS Research reports provide an end-to-end view of the long-acting drug delivery market, spanning injectables, biologics, transdermal patches, and advanced therapeutic platforms.
📊 Whether you’re a pharma executive, biotech innovator, or healthcare investor, these studies offer the insights you need to make data-driven decisions.
